Events

Ukraine's pharmaceutical industry is rapidly evolving: new registration procedures, eCTD implementation, stricter requirements for evidence-based data, and changes in pricing and access to therapy. It is no longer enough for businesses to simply track these changes — they must understand their underlying logic and practical impact on commercial models.

On May 12 in Kyiv, a forum organized by Proxima Research International in partnership with the State Expert Centre of the Ministry of Health of Ukraine will bring together regulators and industry for an open dialogue on the most pressing regulatory changes.

Key topics:

• Regulatory transformation of Ukraine's pharmaceutical market
• Medicinal product registration and bioequivalence studies
• eCTD development and digitalization of regulatory procedures
• Marketing practices and regulatory restrictions
• New models of medicine access and regulatory policy

Formats: Keynote presentations · Panel discussions · Networking sessions

Who should attend: senior management of pharmaceutical companies, pharmacy chains and distributors, heads of regulatory and medical departments, representatives of consulting, analytics, and government bodies.

🔗 Registration is open — view event details

On May 28 in Kyiv and online, one of the largest industry events of the year will take place — a congress organized by Proxima Research International that will bring together representatives of pharmacy retail, pharmaceutical companies, distributors, professional associations, and government authorities.

Pharmacy retail has reached a turning point where old approaches no longer guarantee stability, and new rules are still taking shape. It is more important than ever to see not isolated events, but a complete picture of systemic change — in the context of the Ukrainian market, the European development vector, and global pharmacy retail trends.

Key topics:

• Transformation of the Ukrainian pharmacy market
• The evolving role of the pharmacy in new economic realities
• Economics of pharmacy business: challenges and opportunities
• Impact of regulatory changes on business models
• Practical solutions for resilience and growth under new conditions

Formats: Keynote presentations · Panel discussions · Networking sessions

Who should attend: pharmacy chain and distributor executives, pharmaceutical company representatives, professional associations, regulatory authorities, and industry experts.

🔗 Registration is open — view event details